Scott Cormack
2016
In 2016, Scott Cormack earned a total compensation of $696.6K as Former President and Chief Executive Officer at OncoGenex Pharmaceuticals, a 17% decrease compared to previous year.
Compensation breakdown
| Option Awards | $155,202 |
|---|---|
| Salary | $541,383 |
| Total | $696,585 |
Cormack received $541.4K in salary, accounting for 78% of the total pay in 2016.
Cormack also received $155.2K in option awards.
Rankings
In 2016, Scott Cormack's compensation ranked 9,898th out of 14,075 executives tracked by ExecPay. In other words, Cormack earned more than 29.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,898 out of 14,075 | 30th |
Division Manufacturing | 3,821 out of 5,489 | 30th |
Major group Chemicals And Allied Products | 1,336 out of 1,895 | 30th |
Industry group Drugs | 1,064 out of 1,538 | 31st |
Industry In Vitro and In Vivo Diagnostic Substances | 38 out of 65 | 42nd |
Source: SEC filing on September 21, 2017.
Cormack's colleagues
We found two more compensation records of executives who worked with Scott Cormack at OncoGenex Pharmaceuticals in 2016.